Amydis, Inc.
Los Angeles, US · 1 known investors
Biotech
Founders & leadership
SS
Stella SarrafExecutive Officer, Director
JK
James KhodabakhshDirector
MT
Mervyn TurnerDirector
CA
Christine AylwardDirector
FC
Faith CharlesDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3MraisedDec 2023 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Christine AylwardDirector
- Mervyn TurnerDirector
- Stella SarrafExecutive Officer, Director
- James KhodabakhshDirector
- Jerre L. SteadDirector
- Jack Thrift, CPAExecutive Officer
- Offering amount
- $6M
- Amount sold
- $3M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedDec 2022 · 2 investors · BiotechnologyRule 506(b)
▶$6MraisedDec 2022 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Mervyn TurnerDirector
- Jerre L. SteadDirector
- Christine AylwardDirector
- James KhodabakhshDirector
- Stella SarrafExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $6M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedApr 2022 · 14 investors · BiotechnologyRule 506(b)
▶$5.7MraisedApr 2022 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Stella SarrafExecutive Officer, Director
- James KhodabakhshDirector
- Mervyn TurnerDirector
- Christine AylwardDirector
- Faith CharlesDirector
- Offering amount
- $5.7M
- Amount sold
- $5.7M
- First sale
- Feb 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.